Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2130 (LINC02130)

Target
LINC02130
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2130 (LINC02130) is an annotated human gene that encodes a long intergenic non-coding RNA (lincRNA), which is a subclass of long non-coding RNAs transcribed from genomic regions that do not overlap protein-coding genes[1][3][7]. LincRNAs are typically over 200 nucleotides in length and may regulate gene expression at transcriptional, post-transcriptional, or epigenetic levels. Most lincRNAs, including LINC02130, remain poorly characterized, with functional roles inferred largely from the broader lincRNA family, which is known for fine-tuning gene expression and potentially contributing to genome architecture and regulatory networks[3][7]. LINC02130 is not known to encode a protein, nor is it identified as a direct therapeutic target, nor does it have established roles in specific diseases at present[1][3][7].

Other names
LINC02130
02

Mechanism of action

None. No drugs are known to target this RNA, so no mechanisms applicable.

03

Biological functions

Regulation of gene expression (transcriptional and epigenetic modulation of adjacent or distant genes)Remodeling chromatin and genome architectureRNA stabilizationParticipation in enhancer-associated regulatory activity
04

Disease associations

Other (lincRNAs are known to participate in cancer, developmental disorders, and other diseases, but such a role for LINC02130 itself has not been established)
05

Safety considerations

None specifically described. In general, lincRNAs as a class could pose challenges for targeting due to non-coding status, tissue specificity, and functional redundancy
06

Interacting drugs

None
07

Biomarkers

None established for LINC02130

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2130 (LINC02130).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2130 (LINC02130).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call